About this episode

Dr. Tania Jain discusses myelofibrosis, its impact on bone marrow, symptoms, and personalized treatment options.

Tania Jain, MBBS What does a myelofibrosis (MF) diagnosis really mean, and how does it fit within a group of conditions called myeloproliferative neoplasms, or MPNs? In this episode, we’re joined by Dr. Tania Jain of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD, who helps break it all down in a clear and approachable way. She discusses how myelofibrosis affects the bone marrow, common symptoms to watch for, and how treatment options are tailored to each person. From managing day-to-day challenges to understanding when more advanced treatments may be considered, this conversation focuses on what matters most to patients and families. As Dr. Jain shares, “every patient writes their own story,” noting that advancing research offers genuine hope. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode:  Myelofibrosis (MF) DIPSS/DIPSS plus myelofibrosis scoring Myelofibrosis: Charting the Course for Care Allogeneic stem cell transplantation Acute myeloid leukemia (AML) Clinical Trial Support Center Online Chat Additional Blood Cancer United Support Resources:  Information Specialists   Financial support…

People in this episode

Guest: Tania Jain

Topics covered

• myelofibrosis
• myeloproliferative neoplasms
• treatment options
• patient care
• bone marrow
• symptoms

Keywords

• myelofibrosis
• MPNs
• bone marrow
• treatment options
• patient support
• clinical trials
• symptoms

Sponsors

Takeda Oncology

Mentioned in this episode

Organizations: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Blood Cancer United

More episodes of The Bloodline with Blood Cancer United Podcast

• Chronic Lymphocytic Leukemia (CLL): Managing Treatment and Finding Balance · May 15, 2026 · 43 min

Explore listener stats, chart rankings, contacts and more on the The Bloodline with Blood Cancer United Podcast podcast page.